Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Applications of RNA interference in the treatment of arthritis.

Rai MF, Pan H, Yan H, Sandell LJ, Pham CTN, Wickline SA.

Transl Res. 2019 Dec;214:1-16. doi: 10.1016/j.trsl.2019.07.002. Epub 2019 Jul 10. Review.

PMID:
31351032
2.

Nanoparticle-based delivery of small interfering RNA: challenges for cancer therapy.

Miele E, Spinelli GP, Miele E, Di Fabrizio E, Ferretti E, Tomao S, Gulino A.

Int J Nanomedicine. 2012;7:3637-57. doi: 10.2147/IJN.S23696. Epub 2012 Jul 20. Review.

3.

Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment.

Cummings JC, Zhang H, Jakymiw A.

Transl Res. 2019 Dec;214:92-104. doi: 10.1016/j.trsl.2019.07.010. Epub 2019 Jul 29. Review.

PMID:
31404520
4.

Lipid-based siRNA Delivery Systems: Challenges, Promises and Solutions Along the Long Journey.

Sarisozen C, Salzano G, Torchilin VP.

Curr Pharm Biotechnol. 2016;17(8):728-40. Review.

PMID:
27033509
5.

Biomaterials in siRNA Delivery: A Comprehensive Review.

Ho W, Zhang XQ, Xu X.

Adv Healthc Mater. 2016 Nov;5(21):2715-2731. doi: 10.1002/adhm.201600418. Epub 2016 Oct 4. Review.

PMID:
27700013
6.

MicroRNA: a small molecule with a big biological impact.

Zhou X, Yang PC.

Microrna. 2012;1(1):1.

PMID:
25048083
7.

TransKingdom RNA interference: a bacterial approach to challenges in RNAi therapy and delivery.

Keates AC, Fruehauf J, Xiang S, Li CJ.

Biotechnol Genet Eng Rev. 2008;25:113-27. Review.

PMID:
21412352
8.

siRNA-based therapeutic approaches for rheumatic diseases.

Apparailly F, Jorgensen C.

Nat Rev Rheumatol. 2013 Jan;9(1):56-62. doi: 10.1038/nrrheum.2012.176. Epub 2012 Oct 23. Review.

PMID:
23090506
9.

RNA interference therapeutics for cancer: challenges and opportunities (review).

Bora RS, Gupta D, Mukkur TK, Saini KS.

Mol Med Rep. 2012 Jul;6(1):9-15. doi: 10.3892/mmr.2012.871. Epub 2012 Apr 18. Review.

PMID:
22576734
10.

Advances in siRNA delivery in cancer therapy.

Singh A, Trivedi P, Jain NK.

Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):274-283. doi: 10.1080/21691401.2017.1307210. Epub 2017 Apr 19. Review.

PMID:
28423924
11.

Current issues of RNAi therapeutics delivery and development.

Haussecker D.

J Control Release. 2014 Dec 10;195:49-54. doi: 10.1016/j.jconrel.2014.07.056. Epub 2014 Aug 9. Review.

PMID:
25111131
12.

Update on the development of microRNA and siRNA molecules as regulators of cell physiology.

Laitala-Leinonen T.

Recent Pat DNA Gene Seq. 2010 Jun;4(2):113-21. Review.

PMID:
20550514
13.

Delivery of RNAi Therapeutics to the Airways-From Bench to Bedside.

Qiu Y, Lam JK, Leung SW, Liang W.

Molecules. 2016 Sep 20;21(9). pii: E1249. Review.

14.

Surfactant protein B (SP-B) enhances the cellular siRNA delivery of proteolipid coated nanogels for inhalation therapy.

Merckx P, De Backer L, Van Hoecke L, Guagliardo R, Echaide M, Baatsen P, Olmeda B, Saelens X, Pérez-Gil J, De Smedt SC, Raemdonck K.

Acta Biomater. 2018 Sep 15;78:236-246. doi: 10.1016/j.actbio.2018.08.012. Epub 2018 Aug 15.

PMID:
30118853
15.

The design and exogenous delivery of siRNA for post-transcriptional gene silencing.

Gilmore IR, Fox SP, Hollins AJ, Sohail M, Akhtar S.

J Drug Target. 2004 Jul;12(6):315-40. Review.

PMID:
15545082
16.

RNA interference-based therapy and its delivery systems.

Chen X, Mangala LS, Rodriguez-Aguayo C, Kong X, Lopez-Berestein G, Sood AK.

Cancer Metastasis Rev. 2018 Mar;37(1):107-124. doi: 10.1007/s10555-017-9717-6. Review.

17.

Current preclinical small interfering RNA (siRNA)-based conjugate systems for RNA therapeutics.

Lee SH, Kang YY, Jang HE, Mok H.

Adv Drug Deliv Rev. 2016 Sep 1;104:78-92. doi: 10.1016/j.addr.2015.10.009. Epub 2015 Oct 27. Review.

PMID:
26514375
18.

Polycation-based nanoparticles for RNAi-mediated cancer treatment.

Ballarín-González B, Ebbesen MF, Howard KA.

Cancer Lett. 2014 Sep 28;352(1):66-80. doi: 10.1016/j.canlet.2013.09.023. Epub 2013 Oct 15. Review.

PMID:
24139965
19.

Development of RNAi technology for targeted therapy--a track of siRNA based agents to RNAi therapeutics.

Zhou Y, Zhang C, Liang W.

J Control Release. 2014 Nov 10;193:270-81. doi: 10.1016/j.jconrel.2014.04.044. Epub 2014 May 6. Review.

PMID:
24816071
20.

Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.

Schiffelers RM, Xu J, Storm G, Woodle MC, Scaria PV.

Arthritis Rheum. 2005 Apr;52(4):1314-8.

Supplemental Content

Support Center